Synthesis and anticancer activity of 4-aza-daurinol derivatives
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hayat, Faisal | - |
dc.contributor.author | Park, Seung-Hyuk | - |
dc.contributor.author | Choi, Nam-Song | - |
dc.contributor.author | Lee, Juyeun | - |
dc.contributor.author | Park, Sung Jean | - |
dc.contributor.author | Shin, Dongyun | - |
dc.date.available | 2020-02-28T07:43:53Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-11 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9986 | - |
dc.description.abstract | Daurinol, a natural aryl naphthalene lactone, has been reported to have antiproliferative activity against various cell lines, and has also been shown to be efficacious in an in vivo xenograft mouse model. In this study, we tried to discover a new scaffold that enables both rapid structure-activity relationship study of daurinol and scalable synthesis of active compounds. 4-Aza-daurinol, a bioisosterism-based scaffold of daurinol, was designed and 17 analogues were synthesized and evaluated against five representative cancer cell lines. Among them, the 2,3-dihydrobenzo[b][1,4]dioxinyl derivative was found to be the most potent and showed similar activity and tendency as daurinol. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.relation.isPartOf | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.subject | ARYLNAPHTHALENE LACTONES | - |
dc.subject | THERAPY | - |
dc.subject | LIGNAN | - |
dc.subject | BIOISOSTERISM | - |
dc.subject | INHIBITOR | - |
dc.subject | DAURINOL | - |
dc.title | Synthesis and anticancer activity of 4-aza-daurinol derivatives | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000364971800008 | - |
dc.identifier.doi | 10.1007/s12272-015-0619-2 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.38, no.11, pp.1975 - 1982 | - |
dc.identifier.kciid | ART002048270 | - |
dc.identifier.scopusid | 2-s2.0-84947128021 | - |
dc.citation.endPage | 1982 | - |
dc.citation.startPage | 1975 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 38 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Park, Seung-Hyuk | - |
dc.contributor.affiliatedAuthor | Park, Sung Jean | - |
dc.contributor.affiliatedAuthor | Shin, Dongyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Daurinol | - |
dc.subject.keywordAuthor | Anticancer | - |
dc.subject.keywordAuthor | Bioisosteric | - |
dc.subject.keywordAuthor | Aryltetrahydronaphthalene | - |
dc.subject.keywordAuthor | Structure-activity relationship | - |
dc.subject.keywordPlus | ARYLNAPHTHALENE LACTONES | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | LIGNAN | - |
dc.subject.keywordPlus | BIOISOSTERISM | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.subject.keywordPlus | DAURINOL | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.